DBV Technologies reported $8.92M in Trade Debtors for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
DBV Technologies DBVT:US USD 8.92M 710K
Acadia Pharmaceuticals ACAD:US USD 56.14M 12.75M
Alnylam Pharmaceuticals ALNY:US USD 184.51M 42.24M
Amarin AMRN:US USD 123.38M 20.56M
Biocryst Pharmaceuticals BCRX:US USD 42.61M 1.12M
Biomarin Pharmaceutical BMRN:US USD 419.62M 46.88M
Esperion Therapeutics ESPR:US USD 31.49M 3.64M
Halozyme Therapeutics HALO:US USD 233.3M 43.93M
Insmed INSM:US USD 27.4M 2.08M
Intercept Pharmaceuticals ICPT:US USD 26.17M 1.35M
IONIS PHARMACEUT IONS:US USD 6.64M 106K
Neurocrine Biosciences NBIX:US USD 301.2M 22.2M
Ptc Therapeutics PTCT:US USD 124.46M 11.49M
Sarepta Therapeutics SRPT:US USD 223.45M 6.82M
Ultragenyx Pharmaceutical RARE:US USD 31.16M 6.04M
United Therapeutics UTHR:US USD 231.7M 58.3M
YTE INCY:US USD 618.19M 64.78M